シェバ医療センター
| イスラエル | トルコ | オーストリア | |
| 乳癌化学療法 | から $22,500 | から $1,200 | から $15,000 |
| 大腸癌に対する放射線療法 | - | から $7,000 | から $12,000 |
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
この医師は小児血液学および腫瘍学の分野での第一人者であり、特に小児の血液疾患および骨癌（肉腫）に特化しています。現在、この医師はテルアビブのSourasky Medical Centerの小児血液腫瘍科のディレクターを務め、Dana Children's Hospitalの上級小児科医でもあります。この医師は骨癌および軟部組織肉腫の治療を調整し、血液凝固障害を管理し、早産児の血液学を監督しています。この医師はイスラエル小児血液腫瘍学会（ISPHO）のメンバーです。
この医師はベングリオン大学を卒業し、Kaplan Medical Centerで小児医学を専門とし、Schneider Children's Medical Centerで小児血液学および腫瘍学をさらに専門としました。追加のトレーニングはイタリアのRizzoli Orthopaedic Instituteで骨および軟部組織の腫瘍学において完了しました。
Israeli pediatric oncology centers report a 5-year survival rate between 85% and 90% for Wilms tumor. Leading institutions like Sourasky Medical Center maintain a 90% oncology success rate. Specialized units using precise European protocols achieve survival outcomes reaching 95% for early-stage cases.
Bookimed Expert Insight: Success in Israel is driven by high-volume pediatric specialists like Dr. Hana Golan at Sheba Medical Center. Sheba treats over 2 million patients annually and ranks among the global top 10. Their bone marrow transplant package for Wilms tumor is highly comprehensive. It includes consultations with five different specialists, from nephrologists to immunologists, ensuring multi-system safety during complex treatments.
Patient Consensus: Parents emphasize that catching symptoms like abdominal swelling early is vital for reaching the 90%+ survival mark. They often note that specialized genetic testing for mutations is a critical step before starting treatment protocols.
Sheba Medical Center and Sourasky Medical Center are top Israeli hospitals for pediatric Wilms tumor. These JCI-accredited facilities offer multidisciplinary care through dedicated pediatric hemato-oncology departments. Specialized teams utilize precise diagnostics and research-based therapies to treat high-risk pediatric kidney tumors effectively.
Bookimed Expert Insight: Israeli pediatric centers prioritize long-term health by using kidney-sparing surgical techniques. Sheba Medical Center offers complex bone marrow transplant packages for approximately $160,000 in high-risk cases. These comprehensive programs include 30 hospital days and extensive consultations with specialists in cardiology and nephrology.
Patient Consensus: Parents find it helpful that centers provide dedicated nurse services and specialized pediatric nutrition. Many note that having several specialists coordinate care in one location reduces stress during treatment.
Israeli specialists primarily follow the International Society of Paediatric Oncology (SIOP) protocol for Wilms tumor. This approach prioritizes neoadjuvant chemotherapy to shrink the tumor before surgery. Treatment involves multidimensional stages including surgical resection, targeted radiation, and genomic profiling to ensure a 90% survival rate.
Bookimed Expert Insight: Israeli oncology centers like Sheba Medical Center offer a high-tier contingency protocol for high-risk or relapsed cases. While standard SIOP protocols focus on chemo and surgery, Dr. Hana Golan manages specialized bone marrow transplant packages costing approximately $160,000. These comprehensive packages include 30 days of hospitalization and consultations with five different specialists, reflecting a highly integrated multidisciplinary approach.
Patient Consensus: Parents note that surgery often happens quickly after diagnosis for children under 5. They highlight the necessity of discussing fertility preservation and hearing tests before starting intensive chemotherapy regimens.
Survivors of Wilms tumor treated in Israel may experience late effects years after therapy. High-risk protocols involving chemotherapy or radiation can impact kidney function, heart health, and musculoskeletal development. Israeli centers use risk-adapted strategies and lifelong surveillance to detect and manage these long-term conditions early.
Bookimed Expert Insight: Israeli oncology centers prioritize multidisciplinary long-term care by nesting specialists within pediatric departments. For example, Dr. Roksana Klepper at Sourasky Medical Center is dually certified in pediatric oncology and nephrology. This dual expertise is vital for Wilms survivors, as it ensures kidney protection is integrated directly into the cancer treatment plan rather than as an afterthought.
Patient Consensus: Patients emphasize the importance of having a written survivorship care plan. They note that regular check-ups and avoiding certain medications are necessary to protect their remaining kidney for years to come.
International patients typically start Wilms tumor treatment in Israel within 1 to 5 days after arrival. This rapid timeline covers essential diagnostic verification. Treatment often begins immediately following confirmation. Facilities like Sheba Medical Center prioritize pediatric oncology cases to ensure swift medical intervention.
Bookimed Expert Insight: Israeli medical centers demonstrate high efficiency for pediatric oncology. Sheba Medical Center manages over 2 million patients annually and maintains a global top 10 ranking. Their specialized packages, such as those for bone marrow transplants, include comprehensive diagnostics and 30 hospital nights. This level of integrated care prevents delays between diagnosis and therapy. Such centers frequently handle over 9,000 pediatric cases yearly, ensuring standardized yet rapid protocols for international families.
Patient Consensus: Families emphasize that shipping medical records and pathology slides ahead of travel significantly speeds up the process. They note that while Israeli hospitals move quickly, delays most often come from home-country bureaucracy or insurance approvals.
Israeli pediatric surgeons primarily use radical nephrectomy via subcostal or flank incisions for Wilms tumor removal. These procedures leave a visible scar. Open surgery is the gold standard in JCI-accredited centers like Sheba Medical Center to ensure safe lymph node sampling and complete tumor margins.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center report a 90% average success rate for oncology treatments. While robotic surgery is highlighted at many clinics, our data shows its use for Wilms tumor is strictly limited to specific, smaller cases to avoid tumor rupture. Prioritizing open surgery ensures surgeons can perform thorough lymph node checks, which is vital for accurate staging and long-term survival.
Patient Consensus: Parents note that children's scars heal quickly and often become faint, thin lines by school age. Most emphasize that achieving clear margins is the priority over the final size of the incision.
Children in Israel have direct access to the latest Wilms tumor clinical trials through global partnerships. Leading Israeli centers participate in international protocols with the Children Oncology Group (COG) and International Society of Pediatric Oncology (SIOP). This provides kids with innovative therapies and precision diagnostics frequently ahead of other regions.
Bookimed Expert Insight: Data shows that trial availability is highest at larger academic centers in Tel Aviv and Jerusalem. Sheba Medical Center alone serves over 9,000 children annually. Its Pediatric Hemato-Oncology Division director, Dr. Hana Golan, specializes specifically in high-risk tumors. For complex cases, choosing these high-volume centers increases the likelihood of qualifying for a bone marrow transplant or experimental protocol.
Patient Consensus: Parents note that trial options aren't always mentioned automatically. It is vital to ask oncologists directly for a full list of active international protocols. Families also recommend connecting with local parent networks to stay updated on which major hospitals have open enrollment for specific rare cases.